Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Lymphoma, Non-Hodgkin 1Lymphoma 1Carcinoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 11Biopsy 11Specimen Handling 10Rituximab 9Magnetic Resonance Spectroscopy 9obinutuzumab 6fludarabine 6Prednisone 6Lenalidomide 6pembrolizumab 5Nuclear Medicine Department, Hospital 5X-Rays 4Doxorubicin 4venetoclax 3fludarabine phosphate 3Vincristine 3Tacrolimus 3Mycophenolic Acid 3GSK2636771 3Etoposide 3Busulfan 3Bendamustine Hydrochloride 3trametinib 2tocilizumab 2palbociclib 2osimertinib 2ipatasertib 2ibrutinib 2glofitamab 2erdafitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × poly ICLC × 30 days × Clear all
NCT03789097 2026-05-22

Vaccination With Flt3L, Radiation, and Poly-ICLC

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
17 enrolled
BreastHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡